Annual Accounts Receivable
$229.00 K
+$174.00 K+316.36%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual accounts receivable is $229.00 thousand, with the most recent change of +$174.00 thousand (+316.36%) on June 30, 2024.
- During the last 3 years, BNTC annual accounts receivable has risen by +$204.00 thousand (+816.00%).
- BNTC annual accounts receivable is now at all-time high.
Performance
BNTC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$4000.00
-$225.00 K-98.25%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly accounts receivable is $4000.00, with the most recent change of -$225.00 thousand (-98.25%) on September 30, 2024.
- Over the past year, BNTC quarterly accounts receivable has dropped by -$49.00 thousand (-92.45%).
- BNTC quarterly accounts receivable is now -98.25% below its all-time high of $229.00 thousand, reached on June 30, 2024.
Performance
BNTC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BNTC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +316.4% | -92.5% |
| 3 y3 years | +816.0% | -92.5% |
| 5 y5 years | - | -92.5% |
BNTC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7533.3% | -98.3% | +33.3% |
| 5 y | 5-year | at high | +7533.3% | -98.3% | +33.3% |
| alltime | all time | at high | +7533.3% | -98.3% | +33.3% |
Benitec Biopharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4000.00(-98.3%) |
| Jun 2024 | $229.00 K(+316.4%) | $229.00 K(+332.1%) |
| Mar 2024 | - | $53.00 K(0.0%) |
| Dec 2023 | - | $53.00 K(0.0%) |
| Sep 2023 | - | $53.00 K(-3.6%) |
| Jun 2023 | $55.00 K(+1733.3%) | $55.00 K(-1.8%) |
| Mar 2023 | - | $56.00 K(-17.6%) |
| Dec 2022 | - | $68.00 K(+2166.7%) |
| Sep 2022 | - | $3000.00(0.0%) |
| Jun 2022 | $3000.00 | $3000.00(-40.0%) |
| Mar 2022 | - | $5000.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $5000.00(+66.7%) |
| Sep 2021 | - | $3000.00(-88.0%) |
| Jun 2021 | $25.00 K(-57.6%) | $25.00 K(+150.0%) |
| Mar 2021 | - | $10.00 K(-44.4%) |
| Sep 2020 | - | $18.00 K(-69.5%) |
| Jun 2020 | $59.00 K(-40.0%) | $59.00 K(-38.0%) |
| Dec 2018 | - | $95.10 K(-3.4%) |
| Jun 2018 | $98.40 K | $98.40 K(+301.6%) |
| Mar 2016 | - | $24.50 K(-11.6%) |
| Dec 2015 | - | $27.70 K(-53.7%) |
| Dec 2014 | - | $59.80 K |
FAQ
- What is Benitec Biopharma annual accounts receivable?
- What is the all time high annual accounts receivable for Benitec Biopharma?
- What is Benitec Biopharma annual accounts receivable year-on-year change?
- What is Benitec Biopharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Benitec Biopharma?
- What is Benitec Biopharma quarterly accounts receivable year-on-year change?
What is Benitec Biopharma annual accounts receivable?
The current annual accounts receivable of BNTC is $229.00 K
What is the all time high annual accounts receivable for Benitec Biopharma?
Benitec Biopharma all-time high annual accounts receivable is $229.00 K
What is Benitec Biopharma annual accounts receivable year-on-year change?
Over the past year, BNTC annual accounts receivable has changed by +$174.00 K (+316.36%)
What is Benitec Biopharma quarterly accounts receivable?
The current quarterly accounts receivable of BNTC is $4000.00
What is the all time high quarterly accounts receivable for Benitec Biopharma?
Benitec Biopharma all-time high quarterly accounts receivable is $229.00 K
What is Benitec Biopharma quarterly accounts receivable year-on-year change?
Over the past year, BNTC quarterly accounts receivable has changed by -$49.00 K (-92.45%)